Which has stronger valuation and earnings, BVS or APYX?

Bioventus has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bioventus $568.09M 1.33 $22.73M $0.41 22.07 Apyx Medical $52.84M 3.65 -$11.21M -$0.22 N/A

Is BVS or APYX more profitable?

Bioventus has a net margin of 4.94% compared to Apyx Medical's net margin of -16.40%. Bioventus' return on equity of 29.97% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Bioventus 4.94% 29.97% 9.52% Apyx Medical -16.40% -88.47% -14.94%

Is APYX or BWAY more profitable?

Brainsway has a net margin of 15.68% compared to Apyx Medical's net margin of -16.40%. Brainsway's return on equity of 12.28% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -16.40% -88.47% -14.94% Brainsway 15.68% 12.28% 7.75%

Which has better earnings & valuation, SIBN or APYX?

Apyx Medical has lower revenue, but higher earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SiBone $200.93M 3.39 -$18.90M -$0.39 N/A Apyx Medical $52.84M 3.65 -$11.21M -$0.22 N/A

Is SIBN or APYX more profitable?

SiBone has a net margin of -8.10% compared to Apyx Medical's net margin of -16.40%. SiBone's return on equity of -9.56% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets SiBone -8.10% -9.56% -7.06% Apyx Medical -16.40% -88.47% -14.94%

Which has preferable earnings and valuation, APYX or SGP?

Spyglass Pharma has lower revenue, but higher earnings than Apyx Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apyx Medical $52.84M 3.65 -$11.21M -$0.22 N/A Spyglass Pharma N/A N/A N/A N/A N/A

Is APYX or BBNX more profitable?

Apyx Medical has a net margin of -16.40% compared to Beta Bionics' net margin of -60.27%. Beta Bionics' return on equity of -23.00% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -16.40% -88.47% -14.94% Beta Bionics -60.27% -23.00% -20.55%

Apyx Medical (APYX) Competitors

$4.61 -0.25 (-5.14%)

Closing price 04:00 PM Eastern

Extended Trading

$4.63 +0.02 (+0.43%)

As of 04:26 PM Eastern

Compare

APYX vs. BVS, BWAY, SIBN, SGP, and BBNX

Should you buy Apyx Medical stock or one of its competitors? MarketBeat compares Apyx Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Apyx Medical include Bioventus (BVS), Brainsway (BWAY), SiBone (SIBN), Spyglass Pharma (SGP), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry.

How does Apyx Medical compare to Bioventus?

Bioventus (NASDAQ:BVS) and Apyx Medical (NASDAQ:APYX) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

Bioventus has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioventus	$568.09M	1.33	$22.73M	$0.41	22.07
Apyx Medical	$52.84M	3.65	-$11.21M	-$0.22	N/A

In the previous week, Bioventus had 3 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for Bioventus and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.89 beat Bioventus' score of 1.00 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Bioventus	Positive
Apyx Medical	Very Positive

Bioventus has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market.

Bioventus presently has a consensus target price of $14.00, suggesting a potential upside of 54.70%. Apyx Medical has a consensus target price of $6.50, suggesting a potential upside of 41.00%. Given Bioventus' stronger consensus rating and higher possible upside, equities analysts clearly believe Bioventus is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioventus	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

62.9% of Bioventus shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 33.0% of Bioventus shares are held by company insiders. Comparatively, 15.2% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Bioventus has a net margin of 4.94% compared to Apyx Medical's net margin of -16.40%. Bioventus' return on equity of 29.97% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioventus	4.94%	29.97%	9.52%
Apyx Medical	-16.40%	-88.47%	-14.94%

Summary

Bioventus beats Apyx Medical on 12 of the 15 factors compared between the two stocks.

How does Apyx Medical compare to Brainsway?

Apyx Medical (NASDAQ:APYX) and Brainsway (NASDAQ:BWAY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

Apyx Medical has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market. Comparatively, Brainsway has a beta of 1.2, suggesting that its stock price is 20% more volatile than the broader market.

In the previous week, Brainsway had 2 more articles in the media than Apyx Medical. MarketBeat recorded 3 mentions for Brainsway and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.89 beat Brainsway's score of 0.62 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Apyx Medical	Very Positive
Brainsway	Positive

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 15.2% of Apyx Medical shares are owned by insiders. Comparatively, 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Brainsway has a net margin of 15.68% compared to Apyx Medical's net margin of -16.40%. Brainsway's return on equity of 12.28% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-16.40%	-88.47%	-14.94%
Brainsway	15.68%	12.28%	7.75%

Apyx Medical presently has a consensus price target of $6.50, suggesting a potential upside of 41.00%. Brainsway has a consensus price target of $16.00, suggesting a potential upside of 13.07%. Given Apyx Medical's higher probable upside, research analysts plainly believe Apyx Medical is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
Brainsway	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Brainsway has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	3.65	-$11.21M	-$0.22	N/A
Brainsway	$52.22M	10.86	$7.57M	$0.35	40.43

Summary

Brainsway beats Apyx Medical on 10 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to SiBone?

SiBone (NASDAQ:SIBN) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

SiBone currently has a consensus target price of $23.00, suggesting a potential upside of 49.64%. Apyx Medical has a consensus target price of $6.50, suggesting a potential upside of 41.00%. Given SiBone's stronger consensus rating and higher possible upside, analysts clearly believe SiBone is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

SiBone has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, indicating that its share price is 39% more volatile than the broader market.

In the previous week, SiBone had 4 more articles in the media than Apyx Medical. MarketBeat recorded 5 mentions for SiBone and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.89 beat SiBone's score of 0.65 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
SiBone	Positive
Apyx Medical	Very Positive

Apyx Medical has lower revenue, but higher earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SiBone	$200.93M	3.39	-$18.90M	-$0.39	N/A
Apyx Medical	$52.84M	3.65	-$11.21M	-$0.22	N/A

98.1% of SiBone shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 3.9% of SiBone shares are owned by insiders. Comparatively, 15.2% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

SiBone has a net margin of -8.10% compared to Apyx Medical's net margin of -16.40%. SiBone's return on equity of -9.56% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SiBone	-8.10%	-9.56%	-7.06%
Apyx Medical	-16.40%	-88.47%	-14.94%

Summary

SiBone beats Apyx Medical on 9 of the 17 factors compared between the two stocks.

How does Apyx Medical compare to Spyglass Pharma?

Apyx Medical (NASDAQ:APYX) and Spyglass Pharma (NASDAQ:SGP) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

55.3% of Apyx Medical shares are owned by institutional investors. 15.2% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Apyx Medical and Apyx Medical both had 1 articles in the media. Apyx Medical's average media sentiment score of 1.89 beat Spyglass Pharma's score of 1.87 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Apyx Medical	Very Positive
Spyglass Pharma	Very Positive

Apyx Medical presently has a consensus price target of $6.50, suggesting a potential upside of 41.00%. Spyglass Pharma has a consensus price target of $45.00, suggesting a potential upside of 150.42%. Given Spyglass Pharma's stronger consensus rating and higher possible upside, analysts clearly believe Spyglass Pharma is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
Spyglass Pharma	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Spyglass Pharma has a net margin of 0.00% compared to Apyx Medical's net margin of -16.40%. Spyglass Pharma's return on equity of 0.00% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-16.40%	-88.47%	-14.94%
Spyglass Pharma	N/A	N/A	N/A

Spyglass Pharma has lower revenue, but higher earnings than Apyx Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	3.65	-$11.21M	-$0.22	N/A
Spyglass Pharma	N/A	N/A	N/A	N/A	N/A

Summary

Spyglass Pharma beats Apyx Medical on 6 of the 11 factors compared between the two stocks.

How does Apyx Medical compare to Beta Bionics?

Apyx Medical (NASDAQ:APYX) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

Apyx Medical presently has a consensus target price of $6.50, suggesting a potential upside of 41.00%. Beta Bionics has a consensus target price of $19.70, suggesting a potential upside of 43.59%. Given Beta Bionics' higher probable upside, analysts plainly believe Beta Bionics is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
Beta Bionics	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64

In the previous week, Beta Bionics had 17 more articles in the media than Apyx Medical. MarketBeat recorded 18 mentions for Beta Bionics and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.89 beat Beta Bionics' score of 0.08 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Apyx Medical	Very Positive
Beta Bionics	Neutral

Apyx Medical has a net margin of -16.40% compared to Beta Bionics' net margin of -60.27%. Beta Bionics' return on equity of -23.00% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-16.40%	-88.47%	-14.94%
Beta Bionics	-60.27%	-23.00%	-20.55%

55.3% of Apyx Medical shares are held by institutional investors. 15.2% of Apyx Medical shares are held by company insiders. Comparatively, 5.3% of Beta Bionics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Apyx Medical has higher earnings, but lower revenue than Beta Bionics. Apyx Medical is trading at a lower price-to-earnings ratio than Beta Bionics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	3.65	-$11.21M	-$0.22	N/A
Beta Bionics	$100.25M	6.10	-$73.20M	-$1.51	N/A

Apyx Medical has a beta of 1.39, indicating that its share price is 39% more volatile than the broader market. Comparatively, Beta Bionics has a beta of 3.4, indicating that its share price is 240% more volatile than the broader market.

Summary

Apyx Medical and Beta Bionics tied by winning 8 of the 16 factors compared between the two stocks.

Get Apyx Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APYX vs. The Competition

Export

Metric	Apyx Medical	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$193.02M	$8.16B	$6.43B	$11.71B
Dividend Yield	N/A	2.51%	2.67%	5.55%
P/E Ratio	-20.95	16.10	24.49	23.62
Price / Sales	3.65	6.72	500.49	105.27
Price / Cash	N/A	17.15	42.36	56.09
Price / Book	11.82	3.54	10.43	6.70
Net Income	-$11.21M	$225.32M	$3.56B	$337.26M
7 Day Performance	21.64%	-0.23%	-1.38%	-1.41%
1 Month Performance	25.61%	1.30%	0.86%	1.15%
1 Year Performance	153.30%	-4.40%	19.43%	22.61%

Apyx Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APYX Apyx Medical	2.5857 of 5 stars	$4.61 -5.1%	$6.50 +41.0%	+180.9%	$193.02M	$52.84M	N/A	270
BVS Bioventus	4.3284 of 5 stars	$8.11 +2.3%	$14.00 +72.6%	N/A	$662.43M	$568.09M	19.78	1,200	News Coverage
BWAY Brainsway	2.9479 of 5 stars	$14.56 -5.7%	$16.00 +9.9%	+162.1%	$618.38M	$52.22M	41.60	120	News Coverage Positive News Gap Down
SIBN SiBone	2.323 of 5 stars	$14.01 +1.0%	$23.00 +64.2%	-17.7%	$615.12M	$200.93M	N/A	350
SGP Spyglass Pharma	N/A	$18.36 +0.2%	$45.00 +145.1%	N/A	$613.83M	N/A	N/A	65	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:APYX) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Apyx Medical (APYX) Competitors

APYX vs. BVS, BWAY, SIBN, SGP, and BBNX

How does Apyx Medical compare to Bioventus?

Summary

How does Apyx Medical compare to Brainsway?

Summary

How does Apyx Medical compare to SiBone?

Summary

How does Apyx Medical compare to Spyglass Pharma?

Summary

How does Apyx Medical compare to Beta Bionics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Apyx Medical (APYX) Competitors

APYX vs. BVS, BWAY, SIBN, SGP, and BBNX

How does Apyx Medical compare to Bioventus?

Which has stronger valuation and earnings, BVS or APYX?

Does the media prefer BVS or APYX?

Which has more risk & volatility, BVS or APYX?

Do analysts rate BVS or APYX?

Do institutionals & insiders have more ownership in BVS or APYX?

Is BVS or APYX more profitable?

Summary

How does Apyx Medical compare to Brainsway?

Which has more volatility and risk, APYX or BWAY?

Does the media favor APYX or BWAY?

Do insiders & institutionals have more ownership in APYX or BWAY?

Is APYX or BWAY more profitable?

Do analysts prefer APYX or BWAY?

Which has higher earnings and valuation, APYX or BWAY?

Summary

How does Apyx Medical compare to SiBone?

Do analysts recommend SIBN or APYX?

Which has more volatility and risk, SIBN or APYX?

Does the media refer more to SIBN or APYX?

Which has better earnings & valuation, SIBN or APYX?

Do institutionals & insiders have more ownership in SIBN or APYX?

Is SIBN or APYX more profitable?

Summary

How does Apyx Medical compare to Spyglass Pharma?

Do insiders and institutionals have more ownership in APYX or SGP?

Does the media refer more to APYX or SGP?

Do analysts recommend APYX or SGP?

Is APYX or SGP more profitable?

Which has preferable earnings and valuation, APYX or SGP?

Summary

How does Apyx Medical compare to Beta Bionics?

Do analysts rate APYX or BBNX?

Does the media favor APYX or BBNX?

Is APYX or BBNX more profitable?

Do institutionals and insiders believe in APYX or BBNX?

Which has better earnings & valuation, APYX or BBNX?

Which has more risk & volatility, APYX or BBNX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools